GLP-1 Drug Interactions Your Pharmacist Should Catch

How GLP-1s Affect Other Drugs

The primary mechanism through which GLP-1 medications create drug interactions is delayed gastric emptying. By slowing the rate at which food and medication leave your stomach, GLP-1s can change when and how much of an oral drug gets absorbed. This primarily affects the peak concentration (Cmax) and the time to peak concentration (Tmax) of co-administered oral medications.

The good news: a comprehensive systematic review of drug-drug interaction studies found that while GLP-1 medications consistently delayed absorption timing for co-administered drugs, the total amount of drug absorbed (measured by area under the curve, or AUC) was generally unaffected. In most cases, the clinical significance is low.

But "most cases" isn't "all cases." Several drug classes require specific attention.

Oral Contraceptives

GLP-1 medications can reduce the peak concentration and delay the absorption of oral contraceptive hormones. The semaglutide prescribing information specifically notes this interaction. For combined oral contraceptives (estrogen + progestin), the clinical impact appears modest for most formulations.

The greater concern is with progestin-only pills ("mini-pills"), which have a narrower absorption window and are more sensitive to timing disruptions. If you're taking a progestin-only pill alongside a GLP-1, discuss alternative or supplemental contraception with your prescriber.

This interaction is especially important given that GLP-1 medications are contraindicated in pregnancy. Reliable contraception isn't optional — it's a safety requirement.

Levothyroxine (Thyroid Medication)

Levothyroxine has a narrow therapeutic index and is highly sensitive to absorption conditions. It must be taken on an empty stomach, and even small changes in gastric conditions can shift blood levels. In clinical studies of oral semaglutide, levothyroxine exposure increased by 33% when the two drugs were taken together — potentially pushing patients into hyperthyroid range on a dose that was previously stable.

If you take levothyroxine and start a GLP-1 medication, your provider should check TSH levels 6-8 weeks after initiation and again after any GLP-1 dose change. Maintain consistent timing of your levothyroxine dose relative to your GLP-1 injection day.

Warfarin and Anticoagulants

Warfarin has a notoriously narrow therapeutic index — too little and you risk clots, too much and you risk bleeding. GLP-1 medications delay warfarin absorption (extending Tmax) and can reduce its peak concentration. While most studies found no clinically significant change in INR or overall drug exposure, the narrow margin for error means closer monitoring is warranted.

Best practice: weekly INR monitoring for the first 4 weeks after starting or changing a GLP-1 dose in warfarin patients. Direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) have fewer interaction concerns but should still be discussed with your prescriber.

Insulin and Sulfonylureas

This is the highest-risk interaction category. GLP-1 medications improve insulin sensitivity and lower blood sugar independently. When combined with insulin or medications that stimulate insulin secretion (sulfonylureas like glipizide or glyburide), the risk of hypoglycemia increases significantly.

Standard practice is to proactively reduce insulin doses by 10-20% when initiating GLP-1 therapy, and to reduce sulfonylurea doses by up to 50%. Your provider should not wait for a hypoglycemic episode to make these adjustments — they should be made preemptively.

Other Medications to Monitor

NSAIDs (ibuprofen, naproxen): Can worsen GI side effects when combined with GLP-1 medications. Not a pharmacokinetic interaction, but a practical one — both irritate the GI tract.

Metformin: Generally safe and commonly co-prescribed. GLP-1 medications may slightly delay metformin absorption but don't significantly affect its overall exposure or efficacy.

Statins: GLP-1 medications may delay statin absorption but don't significantly alter their overall exposure. No dose adjustment typically needed.

Acetaminophen: Delayed absorption but unchanged total exposure. No clinical concern at normal doses.

The Coordination Problem

Drug interaction management requires coordination between your GLP-1 prescriber and any other providers managing your medications. The most common failure point is when a telehealth GLP-1 provider doesn't communicate with your primary care doctor, endocrinologist, or cardiologist — and none of them know the full picture.

Give every provider your complete medication list. When starting a GLP-1, explicitly ask your pharmacist to review your entire medication profile for interactions. And if you take any narrow therapeutic index drug — warfarin, levothyroxine, digoxin, phenytoin — flag that to your GLP-1 prescriber before your first dose.